Joshua R. Disbrow is CEO at AYTU BIOSCIENCE, INC (AYTU). They have made 11 open-market trades across 2 companies since 2016, most recently 2026-07-28.
CIK 0001566240
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
11 open-market purchases totalling $1.1M since 2016, never a sale. Across 11 scored buys the stock is down 2.8% at ninety days, and 4.6 points behind the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 36% | 18% | 36% |
| Avg Move | -15.0% | -2.7% | -2.8% |
| Alpha | -21.5% | -3.5% | -4.6% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AYTU | BUY | 2025-06-09 | 2025-06-10 | $1.50 | $100K | -4.8% | +10.1% | +9.1% |
| AYTU | BUY | 2025-02-28 | 2025-03-03 | $1.30 | $20K | -4.7% | -10.2% | +39.1% |
| ZYXI | BUY | 2024-07-29 | 2024-07-30 | $8.32 | $58K | -9.9% | -5.2% | +5.5% |
| AYTU | BUY | 2023-06-14 | 2023-06-15 | $1.86 | $26K | -23.2% | -6.7% | -19.6% |
| AYTU | BUY | 2022-12-19 | 2022-12-21 | $0.22 | $25K | +0.3% | -11.5% | -48.0% |
| AYTU | BUY | 2022-11-18 | 2022-11-28 | $0.24 | $53K | +2.0% | -4.3% | -30.2% |
| AYTU | BUY | 2019-12-19 | 2019-12-19 | $0.89 | $49K | +18.2% | -1.3% | +67.0% |
| AYTU | BUY | 2018-03-06 | 2018-03-07 | $0.45 | $203K | +1.9% | +32.1% | -21.0% |
| AYTU | BUY | 2016-11-02 | 2016-11-04 | $1.50 | $250K | -48.1% | -11.0% | -11.0% |
| AYTU | BUY | 2016-05-06 | 2016-05-16 | $0.40 | $100K | -48.1% | -11.0% | -11.0% |
| AYTU | BUY | 2016-01-20 | 2016-01-21 | $0.65 | $200K | -48.1% | -11.0% | -11.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.